samplepublication date - marketresearchmanufactures and commercializes novel diagnostic technologies...
TRANSCRIPT
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 1 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Publication Date: May 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 2 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Table of Contents Table of Contents ............................................................................................................................................................................... 2
List of Tables .................................................................................................................................................................................. 4
List of Figures ................................................................................................................................................................................. 6
OPKO Health, Inc. Company Snapshot ............................................................................................................................................. 7
OPKO Health, Inc. Company Overview .......................................................................................................................................... 7
Key Information ............................................................................................................................................................................... 7
OPKO Health, Inc. Pipeline Products and Clinical Trials Overview ................................................................................................ 8
OPKO Health, Inc. – Pipeline Analysis Overview ............................................................................................................................. 11
Business Description .................................................................................................................................................................... 11
Key Facts ...................................................................................................................................................................................... 11
OPKO Health, Inc. - Major Products and Services ....................................................................................................................... 12
OPKO Health, Inc. Pipeline Products by Development Stage ...................................................................................................... 13
OPKO Health, Inc. Pipeline Products Overview ............................................................................................................................... 15
4KScore Biomarker Panel - POC Version Prostate Cancer Test .................................................................................................. 15
4KScore Biomarker Panel - POC Version Prostate Cancer Test Product Overview ................................................................. 15
Aquashunt ..................................................................................................................................................................................... 16
Aquashunt Product Overview .................................................................................................................................................... 16
BMS Diagnostic Test - Alzheimer’s Disease ................................................................................................................................. 17
BMS Diagnostic Test - Alzheimer’s Disease Product Overview ................................................................................................ 17
Claros 1 - Vitamin D Test .............................................................................................................................................................. 18
Claros 1 - Vitamin D Test Product Overview ............................................................................................................................. 18
Diagnostic Assay - BNP ................................................................................................................................................................ 19
Diagnostic Assay - BNP Product Overview ............................................................................................................................... 19
Diagnostic Assay - CTnl ................................................................................................................................................................ 20
Diagnostic Assay - CTnl Product Overview ............................................................................................................................... 20
Diagnostic Assay - D-dimer .......................................................................................................................................................... 21
Diagnostic Assay - D-dimer Product Overview .......................................................................................................................... 21
Diagnostic Assay - Folic Acid ........................................................................................................................................................ 22
Diagnostic Assay - Folic Acid Product Overview ....................................................................................................................... 22
Diagnostic Assay - HBV ................................................................................................................................................................ 23
Diagnostic Assay - HBV Product Overview ............................................................................................................................... 23
Diagnostic Assay - HIV ................................................................................................................................................................. 24
Diagnostic Assay - HIV Product Overview ................................................................................................................................ 24
Diagnostic Assay - Lyme Disease ................................................................................................................................................ 25
Diagnostic Assay - Lyme Disease Product Overview ................................................................................................................ 25
Diagnostic Assay - Menopause .................................................................................................................................................... 26
Diagnostic Assay - Menopause Product Overview .................................................................................................................... 26
Diagnostic Assay - Pre-term Bleed ............................................................................................................................................... 27
Diagnostic Assay - Pre-term Bleed Product Overview .............................................................................................................. 27
Diagnostic Assay - Syphilis ........................................................................................................................................................... 28
Diagnostic Assay - Syphilis Product Overview .......................................................................................................................... 28
Diagnostic Assay - TSH ................................................................................................................................................................ 29
Diagnostic Assay - TSH Product Overview ............................................................................................................................... 29
Diagnostic Assay – Fertility ........................................................................................................................................................... 30
Diagnostic Assay – Fertility Product Overview .......................................................................................................................... 30
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 3 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Diagnostic Test - Alzheimer's Disease .......................................................................................................................................... 31
Diagnostic Test - Alzheimer's Disease Product Overview ......................................................................................................... 31
Diagnostic Test - Diabetes ............................................................................................................................................................ 32
Diagnostic Test - Diabetes Product Overview ........................................................................................................................... 32
Diagnostic Test - Multiple Sclerosis .............................................................................................................................................. 33
Diagnostic Test - Multiple Sclerosis Product Overview ............................................................................................................. 33
Diagnostic Test - Non-Small Cell Lung Cancer ............................................................................................................................. 34
Diagnostic Test - Non-Small Cell Lung Cancer Product Overview ............................................................................................ 34
Diagnostic Test - Pancreatic Cancer ............................................................................................................................................ 35
Diagnostic Test - Pancreatic Cancer Product Overview ............................................................................................................ 35
Diagnostic Test - Parkinson's Disease .......................................................................................................................................... 36
Diagnostic Test - Parkinson's Disease Product Overview ......................................................................................................... 36
Diagnostic Test - Tuberculosis ...................................................................................................................................................... 37
Diagnostic Test - Tuberculosis Product Overview ..................................................................................................................... 37
Inspiromatic .................................................................................................................................................................................. 38
Inspiromatic Product Overview .................................................................................................................................................. 38
OPKO Sangia - Testosterone Assay ............................................................................................................................................. 39
OPKO Sangia - Testosterone Assay Product Overview ............................................................................................................ 39
OPKO Sangia - Total PSA Test .................................................................................................................................................... 40
OPKO Sangia - Total PSA Test Product Overview ................................................................................................................... 40
Point-Of-Care System ................................................................................................................................................................... 41
Point-Of-Care System Product Overview .................................................................................................................................. 41
Testosterone Diagnostic Assay - CLIA-Waiver ............................................................................................................................. 42
Testosterone Diagnostic Assay - CLIA-Waiver Product Overview ............................................................................................ 42
OPKO Health, Inc. - Key Competitors ........................................................................................................................................... 43
OPKO Health, Inc. - Key Employees ............................................................................................................................................ 44
OPKO Health, Inc. - Key Employee Biographies .......................................................................................................................... 45
OPKO Health, Inc. - Locations And Subsidiaries .......................................................................................................................... 46
Head Office ................................................................................................................................................................................... 46
Other Locations & Subsidiaries ..................................................................................................................................................... 46
Recent Developments ...................................................................................................................................................................... 47
OPKO Health, Inc., Recent Developments ................................................................................................................................... 47
Appendix .......................................................................................................................................................................................... 48
Methodology ................................................................................................................................................................................. 48
About GlobalData ......................................................................................................................................................................... 48
Disclaimer ..................................................................................................................................................................................... 48
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 4 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
List of Tables
OPKO Health, Inc., Key Facts ............................................................................................................................................................ 7
OPKO Health, Inc. Pipeline Products and Clinical Trials Overview .................................................................................................... 8
OPKO Health, Inc. Pipeline Products by Equipment Type ................................................................................................................. 8
OPKO Health, Inc. Pipeline Products by Indication .......................................................................................................................... 10
OPKO Health, Inc., Key Facts .......................................................................................................................................................... 11
OPKO Health, Inc., Major Products and Services ............................................................................................................................ 12
OPKO Health, Inc. Number of Pipeline Products by Development Stage ........................................................................................ 13
OPKO Health, Inc. Pipeline Products Summary by Development Stage .......................................................................................... 14
4KScore Biomarker Panel - POC Version Prostate Cancer Test - Product Status ........................................................................... 15
4KScore Biomarker Panel - POC Version Prostate Cancer Test - Product Description ................................................................... 15
Aquashunt - Product Status .............................................................................................................................................................. 16
Aquashunt - Product Description ...................................................................................................................................................... 16
BMS Diagnostic Test - Alzheimer’s Disease - Product Status .......................................................................................................... 17
BMS Diagnostic Test - Alzheimer’s Disease - Product Description .................................................................................................. 17
Claros 1 - Vitamin D Test - Product Status ....................................................................................................................................... 18
Claros 1 - Vitamin D Test - Product Description ............................................................................................................................... 18
Diagnostic Assay - BNP - Product Status ......................................................................................................................................... 19
Diagnostic Assay - BNP - Product Description ................................................................................................................................. 19
Diagnostic Assay - CTnl - Product Status ......................................................................................................................................... 20
Diagnostic Assay - CTnl - Product Description ................................................................................................................................. 20
Diagnostic Assay - D-dimer - Product Status ................................................................................................................................... 21
Diagnostic Assay - D-dimer - Product Description ............................................................................................................................ 21
Diagnostic Assay - Folic Acid - Product Status ................................................................................................................................. 22
Diagnostic Assay - Folic Acid - Product Description ......................................................................................................................... 22
Diagnostic Assay - HBV - Product Status ......................................................................................................................................... 23
Diagnostic Assay - HBV - Product Description ................................................................................................................................. 23
Diagnostic Assay - HIV - Product Status .......................................................................................................................................... 24
Diagnostic Assay - HIV - Product Description .................................................................................................................................. 24
Diagnostic Assay - Lyme Disease - Product Status ......................................................................................................................... 25
Diagnostic Assay - Lyme Disease - Product Description .................................................................................................................. 25
Diagnostic Assay - Menopause - Product Status ............................................................................................................................. 26
Diagnostic Assay - Menopause - Product Description ...................................................................................................................... 26
Diagnostic Assay - Pre-term Bleed - Product Status ........................................................................................................................ 27
Diagnostic Assay - Pre-term Bleed - Product Description ................................................................................................................ 27
Diagnostic Assay - Syphilis - Product Status .................................................................................................................................... 28
Diagnostic Assay - Syphilis - Product Description ............................................................................................................................ 28
Diagnostic Assay - TSH - Product Status ......................................................................................................................................... 29
Diagnostic Assay - TSH - Product Description ................................................................................................................................. 29
Diagnostic Assay – Fertility - Product Status .................................................................................................................................... 30
Diagnostic Assay – Fertility - Product Description ............................................................................................................................ 30
Diagnostic Test - Alzheimer's Disease - Product Status ................................................................................................................... 31
Diagnostic Test - Alzheimer's Disease - Product Description ........................................................................................................... 31
Diagnostic Test - Diabetes - Product Status ..................................................................................................................................... 32
Diagnostic Test - Diabetes - Product Description ............................................................................................................................. 32
Diagnostic Test - Multiple Sclerosis - Product Status ....................................................................................................................... 33
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 5 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Diagnostic Test - Multiple Sclerosis - Product Description ............................................................................................................... 33
Diagnostic Test - Non-Small Cell Lung Cancer - Product Status ...................................................................................................... 34
Diagnostic Test - Non-Small Cell Lung Cancer - Product Description .............................................................................................. 34
Diagnostic Test - Pancreatic Cancer - Product Status ..................................................................................................................... 35
Diagnostic Test - Pancreatic Cancer - Product Description .............................................................................................................. 35
Diagnostic Test - Parkinson's Disease - Product Status ................................................................................................................... 36
Diagnostic Test - Parkinson's Disease - Product Description ........................................................................................................... 36
Diagnostic Test - Tuberculosis - Product Status ............................................................................................................................... 37
Diagnostic Test - Tuberculosis - Product Description ....................................................................................................................... 37
Inspiromatic - Product Status ........................................................................................................................................................... 38
Inspiromatic - Product Description .................................................................................................................................................... 38
OPKO Sangia - Testosterone Assay - Product Status ..................................................................................................................... 39
OPKO Sangia - Testosterone Assay - Product Description .............................................................................................................. 39
OPKO Sangia - Total PSA Test - Product Status ............................................................................................................................. 40
OPKO Sangia - Total PSA Test - Product Description ..................................................................................................................... 40
Point-Of-Care System - Product Status ............................................................................................................................................ 41
Point-Of-Care System - Product Description .................................................................................................................................... 41
Testosterone Diagnostic Assay - CLIA-Waiver - Product Status ...................................................................................................... 42
Testosterone Diagnostic Assay - CLIA-Waiver - Product Description .............................................................................................. 42
OPKO Health, Inc., Key Employees ................................................................................................................................................. 44
OPKO Health, Inc., Key Employee Biographies ............................................................................................................................... 45
OPKO Health, Inc., Subsidiaries ...................................................................................................................................................... 46
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 6 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
List of Figures
OPKO Health, Inc. Pipeline Products by Equipment Type ................................................................................................................. 9
OPKO Health, Inc. Pipeline Products by Development Stage .......................................................................................................... 13
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 7 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. Company Snapshot
OPKO Health, Inc. Company Overview
OPKO Health, Inc. (OPKO), formerly eXegenics, Inc., is a biopharmaceutical and diagnostic company. It discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company’s product portfolio includes point-of-care tests, laboratory developed tests (“LDTs”), molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It offers products and vaccines that are used in the treatment of chronic kidney disease, Parkinson’s disease, asthma, hemophilia, obesity, chronic obstructive pulmonary disease (COPD) and chemotherapy-induced nausea and vomiting, among others. The company has its operational presence with its offices located in Chile, Mexico, Spain, Ireland, Canada, Brazil and Israel. OPKO is headquartered in Miami, Florida, the US. The company focuses on expanding its products into mew medical markets, which provides significant opportunities and complement its business. In line with this the company launched its 4Kscore test in Mexico through its wholly owned subsidiary, OPKO Health Mexico.
Key Information
OPKO Health, Inc., Key Facts
Web Address
Turnover (in USD Million)
No. of Employees
Industry Fiscal Year End
Telephone Fax
Ticker Symbol Price
Source: Primary / Secondary Research, GlobalData
As of Apr , 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 8 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. Pipeline Products and Clinical Trials Overview
OPKO Health, Inc. Pipeline Products and Clinical Trials Overview
Type No of Products
Source: Primary / Secondary Research, GlobalData
As of May, 2015
OPKO Health, Inc. Pipeline Products by Equipment Type
Category No of Products No of Clinical Trials
Source: Primary / Secondary Research, GlobalData
As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 9 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. Pipeline Products by Equipment Type
Source: Primary and Secondary Research, GlobalData As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 10 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. Pipeline Products by Indication
Indication No of Products
Source: Primary / Secondary Research, GlobalData
As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 11 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. – Pipeline Analysis Overview
Business Description
Key Facts
OPKO Health, Inc., Key Facts Corporate Address Ticker Symbol, Exchange
Telephone No. of Employees
Fax Fiscal Year End
URL Revenue (in USD Million)
Industry
Locations Source: Primary / Secondary Research, GlobalData
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 12 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. - Major Products and Services
OPKO Health, Inc., Major Products and Services
Products:
Services:
Source: Primary / Secondary Research, GlobalData
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 13 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. Pipeline Products by Development Stage
OPKO Health, Inc. Pipeline Products by Development Stage
Source: Primary and Secondary Research, GlobalData As of May, 2015
OPKO Health, Inc. Number of Pipeline Products by Development Stage
Developmental Stage No of Products
Source: Primary / Secondary Research, GlobalData
As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 14 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. Pipeline Products Summary by Development Stage
Product Name Developmental Stage Equipment Type Territory
Source: Primary / Secondary Research, GlobalData
As of May, 2015 SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 15 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. Pipeline Products Overview
4KScore Biomarker Panel - POC Version Prostate Cancer Test
4KScore Biomarker Panel - POC Version Prostate Cancer Test Product Overview
4KScore Biomarker Panel - POC Version Prostate Cancer Test - Product Status
Source: Primary / Secondary Research, GlobalData
As of May, 2015
4KScore Biomarker Panel - POC Version Prostate Cancer Test - Product Description
Source: Primary / Secondary Research, GlobalData
As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 16 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Aquashunt
Aquashunt Product Overview
Aquashunt - Product Status
Source: Primary / Secondary Research, GlobalData
As of May, 2015
Aquashunt - Product Description
Source: Primary / Secondary Research, GlobalData
As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 17 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
BMS Diagnostic Test - Alzheimer’s Disease
BMS Diagnostic Test - Alzheimer’s Disease Product Overview
BMS Diagnostic Test - Alzheimer’s Disease - Product Status
Source: Primary / Secondary Research, GlobalData
As of May, 2015
BMS Diagnostic Test - Alzheimer’s Disease - Product Description
Source: Primary / Secondary Research, GlobalData
As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 18 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Claros 1 - Vitamin D Test
Claros 1 - Vitamin D Test Product Overview
Claros 1 - Vitamin D Test - Product Status
Source: Primary / Secondary Research, GlobalData
As of May, 2015
Claros 1 - Vitamin D Test - Product Description
Source: Primary / Secondary Research, GlobalData
As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 19 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Diagnostic Assay - BNP
Diagnostic Assay - BNP Product Overview
Diagnostic Assay - BNP - Product Status
Source: Primary / Secondary Research, GlobalData
As of May, 2015
Diagnostic Assay - BNP - Product Description
Source: Primary / Secondary Research, GlobalData
As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 20 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Diagnostic Assay - CTnl
Diagnostic Assay - CTnl Product Overview
Diagnostic Assay - CTnl - Product Status
Source: Primary / Secondary Research, GlobalData
As of May, 2015
Diagnostic Assay - CTnl - Product Description
Source: Primary / Secondary Research, GlobalData
As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 43 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. - Key Competitors
The following companies are the major competitors of OPKO Health, Inc.:
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 44 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. - Key Employees
OPKO Health, Inc., Key Employees
Name Job Title Board Level Since Age
Source: Primary / Secondary Research, GlobalData
As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 45 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. - Key Employee Biographies
OPKO Health, Inc., Key Employee Biographies
Source: Primary / Secondary Research, GlobalData
As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 46 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
OPKO Health, Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
OPKO Health, Inc., Subsidiaries
Source: Primary / Secondary Research, GlobalData
As of May, 2015
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 47 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Recent Developments
OPKO Health, Inc., Recent Developments
SAMPLE
OPKO Health, Inc. (OPK) - Product Pipeline Analysis, 2015 Update Reference Code: GDME41384PD Page 48 © GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
Appendix
The data and analysis within this report is driven by GlobalData. GlobalData gives you key information to drive sales, investment and deal making activity in your business. Our coverage includes 200,000 + reports on 185,000+ companies (including 150,000+ private) across 200+ countries and 29 industries. The key industries include Alternative Energy, Oil & Gas, Clean Technology, Technology and Telecommunication, Pharmaceutical and Healthcare, Power, Financial Services, Chemical and Metal & Mining.
Methodology
GlobalData company reports are based on a core set of research techniques which ensure the best possible level of quality and accuracy of data. The key sources used include: • Company Websites • Company Annual Reports • SEC Filings • Press Releases • Proprietary Databases Notes • Financial information for the company is taken from the most recently published annual reports or SEC filings • The financial and operational data reported for the company is as per the industry defined standards • Currencies are converted at current rates, with average annual rates taken for historic conversions • Only Ongoing clinical trials are covered in the report specific to the pipeline products • In the 'Major Products and Services section, complete list of products are not provided • 'Recent Developments' section has news posted in the last three months
About GlobalData
GlobalData is one of the world’s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally. Our highly qualified team of Analysts, Researchers, and Solution Consultants use proprietary data sources and various tools and techniques to gather, analyze and represent the latest and the most reliable information essential for businesses to sustain a competitive edge. Data is continuously updated and revised by large teams of research experts, so that it always reflects the latest events and information. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research material for this series and its other reports. GlobalData offers comprehensive geographic coverage across world’s most important sectors, focusing particularly on energy and healthcare.
Disclaimer
All Rights Reserved No part of this publication may be reproduced, stored in a retrieval system or transmitted in any form by any means, electronic, mechanical, photocopying, recording or otherwise, without the prior permission of the publisher, GlobalData SAMPLE